Ioulia Vardaki

Senior Scientific Associate - Clinical Data & Science at Intelligencia

Ioulia Vardaki has a diverse work experience in the field of scientific research. Ioulia currently works at Intelligencia as a Senior Scientific Associate, specializing in Clinical Data & Science. Prior to this role, Ioulia worked as a Doctoral Student at Karolinska Institutet, where they focused their research on the molecular and functional properties of exosomes in the metastatic prostate cancer bone microenvironment. Ioulia conducted their research at MD Anderson Cancer Center in Houston, Texas, fulfilling their research obligations for their PhD. Earlier in their career, Ioulia worked as a Research Assistant II at MD Anderson Cancer Center, where they conducted a variety of experiments related to exosome research. Ioulia also gained experience as a Pre-PhD student at Karolinska Institutet, where they performed experiments, trained undergraduate students, and taught basic laboratory techniques. Additionally, Ioulia worked as an Intern at the Biochemistry Lab of the General Hospital "G.Genimmatas", where they operated automated biochemistry analyzers and conducted various biochemistry and immunological analyses.

Ioulia Vardaki completed their Bachelor's degree in Biology, General at Ethnikon kai Kapodistriakon Panepistimion Athinon in 2013. Ioulia then pursued a Master's degree in Molecular Medicine at Uppsala University from 2013 to 2015. In terms of additional certifications, they obtained the Introduction to Mice certification from AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE AALAS in September 2016. In June 2016, they also obtained the Aseptic Technique for Rodent Survival Surgery certification from the same institution. More recently, in December 2021, they obtained the Advanced ICH GCP Certification from CCRPS. Additionally, in January 2022, they obtained the MSL career suitability certification from SCIENCE to PHARMA (FSTP) - Board Certified MSL training.

Links

Timeline

  • Senior Scientific Associate - Clinical Data & Science

    March, 2022 - present